Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 70.04 M70.65 M68.94 M70.7 M66.54 M 276.83 M Research & development ————— — Operating income 24.19 M18.88 M12.33 M-172.54 M18.5 M -122.84 M Non-Operating Income, Total -11.63 M-15.31 M-12.28 M-13.87 M-15.88 M -57.34 M Interest expense, net of interest capitalized 19.8 M18.23 M16.63 M17.05 M16.98 M 68.89 M Non-Operating Income, excl. Interest Expenses -15.22 M-15.02 M-16.13 M-15.98 M-16.53 M -63.65 M Unusual income/expense 3.59 M-296 K3.85 M2.1 M658 K 6.32 M Pretax income 12.56 M3.56 M51 K-186.41 M2.62 M -180.18 M Equity in earnings ————— — Taxes 9.31 M10.29 M11.12 M-15.88 M7.8 M 13.32 M Non-controlling/minority interest 1.86 M1.26 M2.31 M1.96 M2.43 M 7.96 M After tax other income/expense ————— — Net income before discontinued operations 1.38 M-7.99 M-13.37 M-172.49 M-7.61 M -201.46 M Discontinued operations ————— — Net income 1.38 M-7.99 M-13.37 M-172.49 M-7.61 M -201.46 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 1.38 M-7.99 M-13.37 M-172.49 M-7.61 M -201.46 M Basic earnings per share (Basic EPS) 0.03-0.17-0.28-3.57-0.16 -4.18 Diluted earnings per share (Diluted EPS) 0.03-0.17-0.28-3.57-0.16 -4.18 Average basic shares outstanding 47.77 M48.06 M48.46 M48.21 M48.58 M — Diluted shares outstanding 48.23 M48.06 M48.46 M48.21 M48.58 M — EBITDA 24.7 M19.35 M12.93 M-140.9 M19.23 M -89.39 M EBIT 24.19 M18.88 M12.33 M-172.54 M18.5 M -122.84 M Cost of revenue 414.55 M399.27 M413.63 M443.23 M387.87 M 1.64 B Other cost of goods sold 414.55 M399.27 M413.63 M443.23 M387.87 M 1.64 B Depreciation & amortization (cash flow) 510 K475 K602 K31.64 M733 K 33.45 M